K. Xiao

Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19

X. Chai, Liang Tang, Mingxian Chen, 2020, Cardiovascular therapeutics.

Coronavirus Disease 2019 with Comorbid Pulmonary Tuberculosis: A Case Report

B. Cao, K. Xiao, M. Wei, 2020 .

Successful Treatment with Ensartinib After Alectinib-induced Hyperbilirubinemia in ALK-Positive NSCLC

J. Stebbing, Yongchang Zhang, J. Yen, 2021, OncoTargets and therapy.

β-TrCP Restricts Lipopolysaccharide (LPS)-Induced Activation of TRAF6-IKK Pathway Upstream of IκBα Signaling

Jing Xu, K. Xiao, Jun Wang, 2018, Front. Immunol..

Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis

J. Stebbing, Song Xu, K. Xiao, 2022, Oncology Research and Treatment.

Changes in CT manifestations of patients with mild to moderate coronavirus disease 2019 in a Fangcang Shelter Hospital

W. Pu, Haijun Deng, Yang Wang, 2020 .

Bioinformatics prediction of differential miRNAs in non-small cell lung cancer

Yang Wang, Yang Wang, K. Xiao, 2021, PloS one.